Related Experiment Video
Updated: Jul 8, 2026
09:18
A Sensitive Method to Quantify Senescent Cancer Cells
Published on: August 2, 2013
Telomeres, stem cells, senescence, and cancer
Norman E Sharpless1, Ronald A DePinho
1Department of Medicine and Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-8212, USA. nes@med.unc.edu
The Journal of Clinical Investigation
|January 15, 2004
Summary
Mammalian aging is linked to declining tissue stem cell function. Protective anti-cancer mechanisms in stem cells may inadvertently limit their lifespan, contributing to the aging process.
Area of Science:
- Gerontology
- Stem Cell Biology
- Cancer Biology
Background:
- Mammalian aging involves a decrease in the regenerative capabilities of tissue stem cells.
- Stem cells possess self-renewal properties but are susceptible to oncogenic mutations.
- Tumor suppressor mechanisms, including p16(INK4a)-Rb, ARF-p53, and telomere regulation, protect against stem cell malignancy.
Purpose of the Study:
- To investigate the relationship between anti-cancer mechanisms in stem cells and the aging process.
- To explore how tumor suppressor pathways influence stem cell lifespan and function.
Main Methods:
- Analysis of molecular pathways involved in stem cell aging.
- Examination of tumor suppressor mechanisms (p16(INK4a)-Rb, ARF-p53, telomere) in the context of aging.
- Comparative study of stem cell function across different age groups (implied).
Main Results:
- A decline in tissue stem cell restorative capacity contributes to mammalian aging.
- While crucial for preventing cancer, these protective pathways appear to impose limitations on stem cell longevity.
- Overlapping tumor suppressor mechanisms, though beneficial against oncogenesis, may also restrict stem cell lifespan.
Conclusions:
- The same pathways that protect stem cells from cancer may also drive aspects of aging.
- Understanding these trade-offs is critical for developing interventions for age-related decline.
- Targeting these mechanisms could potentially enhance stem cell function and mitigate aging effects.
Related Concept Videos
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...